Literature DB >> 16313186

Nuclear magnetic resonance structural studies of a potassium channel-charybdotoxin complex.

Liping Yu1, Chaohong Sun, Danying Song, Jianwei Shen, Nan Xu, Angelo Gunasekera, Philip J Hajduk, Edward T Olejniczak.   

Abstract

Ion channels play critical roles in signaling processes and are attractive targets for treating various diseases. Here we describe an NMR-based strategy for structural analyses of potassium channel-ligand complexes using KcsA (residues 1-132, with six mutations to impart toxin binding and to mimic the eukaryotic hERG channel). Using this approach, we determined the solution structure of KcsA in complex with the high-affinity peptide antagonist charybdotoxin. The structural data reveal how charybdotoxin binds to the closed form of KcsA and makes specific contacts with the extracellular surface of the ion channel, resulting in pore blockage. This represents the first direct structural information about an ion channel complexed to a peptide antagonist and provides an experimental framework for understanding and interpreting earlier mutational analyses. The strategy presented here overcomes many of the limitations of conventional NMR approaches to helical membrane protein structure determination and can be applied in the study of the binding of druglike molecules to this important class of proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313186     DOI: 10.1021/bi051656d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  Permeation and block of the Kv1.2 channel examined using brownian and molecular dynamics.

Authors:  Dan Gordon; Shin-Ho Chung
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

2.  Modeling the binding of three toxins to the voltage-gated potassium channel (Kv1.3).

Authors:  Rong Chen; Anna Robinson; Dan Gordon; Shin-Ho Chung
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

3.  Recent Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral Membrane Proteins.

Authors:  Hak Jun Kim; Stanley C Howell; Wade D Van Horn; Young Ho Jeon; Charles R Sanders
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-11-01       Impact factor: 9.795

4.  Atomistic insights into human Cys-loop receptors by solution NMR.

Authors:  David D Mowrey; Monica N Kinde; Yan Xu; Pei Tang
Journal:  Biochim Biophys Acta       Date:  2014-03-28

5.  Measurement of 15N relaxation in the detergent-solubilized tetrameric KcsA potassium channel.

Authors:  Jordan H Chill; John M Louis; James L Baber; Ad Bax
Journal:  J Biomol NMR       Date:  2006-09-20       Impact factor: 2.835

6.  Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxins.

Authors:  Cyril Pimentel; Sarrah M'Barek; Violetta Visan; Stephan Grissmer; François Sampieri; Jean-Marc Sabatier; Hervé Darbon; Ziad Fajloun
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

Review 7.  Solution NMR of membrane proteins in bilayer mimics: small is beautiful, but sometimes bigger is better.

Authors:  Sébastien F Poget; Mark E Girvin
Journal:  Biochim Biophys Acta       Date:  2007-09-20

8.  Local and global structure of the monomeric subunit of the potassium channel KcsA probed by NMR.

Authors:  Jordan H Chill; John M Louis; Frank Delaglio; Ad Bax
Journal:  Biochim Biophys Acta       Date:  2007-08-24

9.  Structural biology of transmembrane domains: efficient production and characterization of transmembrane peptides by NMR.

Authors:  Jian Hu; Huajun Qin; Conggang Li; Mukesh Sharma; Timothy A Cross; Fei Philip Gao
Journal:  Protein Sci       Date:  2007-10       Impact factor: 6.725

10.  Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs.

Authors:  Sang Ho Park; Stanley J Opella
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.